JP2022532917A5 - - Google Patents
Info
- Publication number
- JP2022532917A5 JP2022532917A5 JP2021568804A JP2021568804A JP2022532917A5 JP 2022532917 A5 JP2022532917 A5 JP 2022532917A5 JP 2021568804 A JP2021568804 A JP 2021568804A JP 2021568804 A JP2021568804 A JP 2021568804A JP 2022532917 A5 JP2022532917 A5 JP 2022532917A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- immunogen
- holotoxin
- polypeptide
- sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962851040P | 2019-05-21 | 2019-05-21 | |
| US62/851,040 | 2019-05-21 | ||
| PCT/US2020/034070 WO2020237090A1 (en) | 2019-05-21 | 2020-05-21 | Vaccine compositions for clostridium difficile |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022532917A JP2022532917A (ja) | 2022-07-20 |
| JP2022532917A5 true JP2022532917A5 (https=) | 2023-05-26 |
| JP7637988B2 JP7637988B2 (ja) | 2025-03-03 |
Family
ID=73458679
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021568804A Active JP7637988B2 (ja) | 2019-05-21 | 2020-05-21 | クロストリジウム・ディフィシルのワクチン組成物 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20220062401A1 (https=) |
| EP (1) | EP3972638A4 (https=) |
| JP (1) | JP7637988B2 (https=) |
| CN (1) | CN114126644A (https=) |
| BR (1) | BR112021023119A2 (https=) |
| CA (1) | CA3141165A1 (https=) |
| MX (3) | MX2021014097A (https=) |
| WO (1) | WO2020237090A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB202205833D0 (en) | 2022-04-21 | 2022-06-08 | Glaxosmithkline Biologicals Sa | Bacteriophage |
| EP4658302A1 (en) * | 2023-02-02 | 2025-12-10 | GlaxoSmithKline Biologicals S.A. | Immunogenic composition |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1000155A1 (en) * | 1997-06-20 | 2000-05-17 | QUEEN MARY & WESTFIELD COLLEGE | Immunogenic fragments of toxin a of clostridium difficile |
| US10046040B2 (en) * | 2009-11-16 | 2018-08-14 | University Of Maryland, Baltimore | Multivalent live vector vaccine against Clostridium difficile-associated disease |
| WO2013084071A2 (en) * | 2011-12-08 | 2013-06-13 | Novartis Ag | Clostridium difficile toxin-based vaccine |
| GB201206070D0 (en) * | 2012-04-04 | 2012-05-16 | Health Prot Agency | Clostridium difficile antigens |
| BR122016023101B1 (pt) * | 2012-10-21 | 2022-03-22 | Pfizer Inc | Polipeptídeo, composição imunogênica que o compreende, bem como célula recombinante derivada de clostridium difficile |
| WO2014086787A1 (en) * | 2012-12-05 | 2014-06-12 | Glaxosmithkline Biologicals S.A. | Immunogenic composition |
| WO2015123767A1 (en) * | 2014-02-18 | 2015-08-27 | The Hospital For Sick Children | Compositions and methods for treating or preventing clostridium infection |
| CA2976976C (en) * | 2015-02-19 | 2023-02-28 | Immune Biosolutions Inc. | Clostridium difficile toxins a and/or b antigen and epitope antibody, and pharmaceutical uses thereof |
| WO2019143552A1 (en) * | 2018-01-16 | 2019-07-25 | Children's Medical Center Corporation | Compositions and methods for inhibiting wnt signaling |
-
2020
- 2020-05-21 EP EP20810329.1A patent/EP3972638A4/en active Pending
- 2020-05-21 BR BR112021023119A patent/BR112021023119A2/pt unknown
- 2020-05-21 JP JP2021568804A patent/JP7637988B2/ja active Active
- 2020-05-21 WO PCT/US2020/034070 patent/WO2020237090A1/en not_active Ceased
- 2020-05-21 CA CA3141165A patent/CA3141165A1/en active Pending
- 2020-05-21 CN CN202080049940.3A patent/CN114126644A/zh active Pending
- 2020-05-21 MX MX2021014097A patent/MX2021014097A/es unknown
-
2021
- 2021-11-17 MX MX2026001281A patent/MX2026001281A/es unknown
- 2021-11-17 MX MX2026001280A patent/MX2026001280A/es unknown
- 2021-11-19 US US17/531,058 patent/US20220062401A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011004753A5 (https=) | ||
| JP7146926B2 (ja) | Ｃｄ４ヘルパーｔ細胞エピトープの融合ペプチドおよびそのワクチン | |
| CN107033250A (zh) | 牛冠状病毒重组多表位抗原及其应用 | |
| EP2532363B1 (en) | Use of flagellins from the genus marinobacter as vaccination adjuvants | |
| RU2015106916A (ru) | Полипептиды clostridium difficile в виде вакцины | |
| JP2022532917A5 (https=) | ||
| JP2015529677A5 (https=) | ||
| CN101302527A (zh) | 重排噬菌体e基因、含有该基因的打孔质粒载体及其应用 | |
| CN105664148A (zh) | 一种基因工程亚单位混合疫苗及其制备方法和应用 | |
| CN103233017B (zh) | 毒害艾美耳球虫的配子体抗原gam22基因及其应用 | |
| CN101319011B (zh) | 多型别hcv-e1表位复合免疫原及其编码基因与应用 | |
| TWI782542B (zh) | 一種鞭毛蛋白的重組蛋白及其用途 | |
| CN103421817B (zh) | 人工合成的猪繁殖与呼吸综合征病毒多表位基因及应用 | |
| CN118530314B (zh) | 广谱型流感疫苗抗原片段、重组益生菌及应用 | |
| Ho et al. | A nanodiamond-formulated plant protein induces robust immunity against porcine epidemic diarrhea virus in piglets | |
| CN116514994B (zh) | 一种大肠杆菌多菌毛表位融合蛋白及其制备方法与应用 | |
| CN115850398B (zh) | 新型冠状病毒奥密克戎系列变异株的多肽组合物及其应用 | |
| WO2017044890A1 (en) | Bird flu vaccine combination comprising virus-like particles and novel adjuvants | |
| CN104593385A (zh) | 柔嫩艾美耳球虫配子体抗原gam59基因及其应用 | |
| CN107974458A (zh) | 表达猪丹毒杆菌重组蛋白GAPDH的基因gapdh及其重组大肠杆菌与应用 | |
| CN101880328A (zh) | 微小隐孢子虫Th多表位基因和融合蛋白及其应用 | |
| CN121426973B (zh) | 一种牛a群轮状病毒多表位融合蛋白及其应用 | |
| CN112375127B (zh) | 一种用作支气管败血波氏菌病疫苗的重组蛋白及其应用 | |
| CN100409900C (zh) | 葡萄球菌肠毒素a基因及其编码蛋白的新用途 | |
| CN104561047A (zh) | 毒害艾美耳球虫配子体抗原Engam59基因及其应用 |